Compare Stocks: AGFY, CRDL, LENZ, and AARD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AARD Aardvark Therapeutics	$6.54 +2.0%	$5.65	$3.35 ▼ $17.94	$140.28M	3.81	137,129 shs	69,139 shs
AGFY Agrify	$22.22 +7.9%	$23.78	$13.22 ▼ $48.84	$44.51M	9.96	31,892 shs	2,035 shs
CRDL Cardiol Therapeutics	$1.80 +5.3%	$1.18	$0.88 ▼ $1.82	$198.16M	0.72	971,333 shs	1.73 million shs
LENZ LENZ Therapeutics	$4.73 +2.8%	$5.64	$4.53 ▼ $50.40	$144.53M	0.65	906,528 shs	701,622 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AARD Aardvark Therapeutics	-2.44%	-12.19%	+2.40%	+40.26%	-42.77%
AGFY Agrify	-1.72%	-17.61%	-8.41%	-28.70%	-33.58%
CRDL Cardiol Therapeutics	+12.50%	+25.74%	+48.70%	+29.55%	+53.36%
LENZ LENZ Therapeutics	-8.73%	-11.88%	-6.69%	-37.33%	-88.31%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AARD Aardvark Therapeutics	$6.54 +2.0%	$5.65	$3.35 ▼ $17.94	$140.28M	3.81	137,129 shs	69,139 shs
AGFY Agrify	$22.22 +7.9%	$23.78	$13.22 ▼ $48.84	$44.51M	9.96	31,892 shs	2,035 shs
CRDL Cardiol Therapeutics	$1.80 +5.3%	$1.18	$0.88 ▼ $1.82	$198.16M	0.72	971,333 shs	1.73 million shs
LENZ LENZ Therapeutics	$4.73 +2.8%	$5.64	$4.53 ▼ $50.40	$144.53M	0.65	906,528 shs	701,622 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AARD Aardvark Therapeutics	-2.44%	-12.19%	+2.40%	+40.26%	-42.77%
AGFY Agrify	-1.72%	-17.61%	-8.41%	-28.70%	-33.58%
CRDL Cardiol Therapeutics	+12.50%	+25.74%	+48.70%	+29.55%	+53.36%
LENZ LENZ Therapeutics	-8.73%	-11.88%	-6.69%	-37.33%	-88.31%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AARD Aardvark Therapeutics	2.46	Hold	$16.30	149.24% Upside
AGFY Agrify	0.00	N/A	N/A	N/A
CRDL Cardiol Therapeutics	2.33	Hold	$8.50	372.22% Upside
LENZ LENZ Therapeutics	2.38	Hold	$28.80	508.88% Upside

Current Analyst Ratings Breakdown

Latest AGFY, CRDL, LENZ, and AARD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2026	LENZ LENZ Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$12.00 ➝ $7.00
8/12/2026	LENZ LENZ Therapeutics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/11/2026	LENZ LENZ Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/20/2026	AARD Aardvark Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$6.00
7/15/2026	LENZ LENZ Therapeutics	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/14/2026	CRDL Cardiol Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/7/2026	LENZ LENZ Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/2/2026	AARD Aardvark Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/24/2026	CRDL Cardiol Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/17/2026	LENZ LENZ Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/27/2026	AARD Aardvark Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AARD Aardvark Therapeutics	N/A	N/A	N/A	N/A	$4.90 per share	N/A
AGFY Agrify	$12.26M	3.63	N/A	N/A	$10.47 per share	2.12
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	$0.11 per share	N/A
LENZ LENZ Therapeutics	$19.09M	7.79	N/A	N/A	$9.09 per share	0.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AARD Aardvark Therapeutics	-$57.59M	-$3.21	N/A	N/A	N/A	N/A	-66.35%	-60.08%	N/A
AGFY Agrify	-$41.75M	-$22.65	N/A	N/A	N/A	-424.11%	-185.90%	-72.67%	N/A
CRDL Cardiol Therapeutics	-$24.20M	-$0.28	N/A	N/A	N/A	N/A	-198.17%	-150.56%	N/A
LENZ LENZ Therapeutics	-$82.13M	-$4.09	N/A	N/A	N/A	-586.74%	-52.16%	-47.90%	N/A

Latest AGFY, CRDL, LENZ, and AARD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	CRDL Cardiol Therapeutics	-$0.09	-$0.04	+$0.05	-$0.04	N/A	N/A
8/11/2026	Q2 2026	AARD Aardvark Therapeutics	-$0.87	-$0.66	+$0.21	-$0.66	N/A	N/A
8/11/2026	Q2 2026	LENZ LENZ Therapeutics	-$1.05	-$1.02	+$0.03	-$1.02	$2.38 million	$5.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AARD Aardvark Therapeutics	N/A	N/A	N/A	N/A	N/A
AGFY Agrify	N/A	N/A	N/A	N/A	N/A
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	N/A
LENZ LENZ Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AARD Aardvark Therapeutics	N/A	8.06	8.06
AGFY Agrify	1.43	2.64	2.52
CRDL Cardiol Therapeutics	N/A	4.39	4.39
LENZ LENZ Therapeutics	N/A	10.40	10.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AARD Aardvark Therapeutics	N/A
AGFY Agrify	5.98%
CRDL Cardiol Therapeutics	12.49%
LENZ LENZ Therapeutics	54.32%

Insider Ownership

Company	Insider Ownership
AARD Aardvark Therapeutics	17.80%
AGFY Agrify	2.16%
CRDL Cardiol Therapeutics	5.25%
LENZ LENZ Therapeutics	8.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AARD Aardvark Therapeutics	18	21.88 million	17.99 million	N/A
AGFY Agrify	140	2.00 million	1.96 million	Not Optionable
CRDL Cardiol Therapeutics	20	115.89 million	109.80 million	Not Optionable
LENZ LENZ Therapeutics	110	31.42 million	28.75 million	N/A

AGFY, CRDL, LENZ, and AARD Headlines

Recent News About These Companies

Q3 EPS Estimate for LENZ Therapeutics Increased by Analyst

August 14 at 8:12 AM | marketbeat.com

LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary

August 13 at 3:29 PM | finance.yahoo.com

Lenz drops as BofA downgrades on a slower VIZZ launch

August 13 at 3:29 PM | msn.com

Lenz outlines July telehealth and national TV push as VIZZ scripts rise over 45% month over month

August 12 at 11:11 PM | seekingalpha.com

LENZ Therapeutics, Inc. (LENZ) Q2 2026 Earnings Call Transcript

August 12 at 2:00 AM | seekingalpha.com

LENZ Therapeutics Q2 Earnings Call Highlights

August 11 at 7:03 PM | marketbeat.com

LENZ Therapeutics (NASDAQ:LENZ) Issues Earnings Results, Beats Estimates By $0.03 EPS

August 11 at 6:40 PM | marketbeat.com

LENZ Therapeutics, Inc. (LENZ) Reports Q2 Loss, Beats Revenue Estimates

August 11 at 6:26 PM | zacks.com

LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

August 11 at 4:05 PM | globenewswire.com

LENZ Therapeutics Q2 2026 earnings preview

August 11 at 1:12 AM | msn.com

LENZ Therapeutics Inc (LENZ) Q2 2026 Earnings Report Preview: What To Look For

August 10, 2026 | finance.yahoo.com

LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026

August 4, 2026 | globenewswire.com

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $29.80 Consensus Price Target from Analysts

August 4, 2026 | americanbankingnews.com

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Hold" from Brokerages

July 30, 2026 | marketbeat.com

Earnings Preview: LENZ Therapeutics, Inc. (LENZ) Q2 Earnings Expected to Decline

July 22, 2026 | zacks.com

LENZ Therapeutics (LENZ) Projected to Post Earnings on Wednesday

July 22, 2026 | marketbeat.com

LENZ Therapeutics (NASDAQ:LENZ) Rating Lowered to Strong Sell at Zacks Research

July 17, 2026 | marketbeat.com

LENZ Therapeutics Stock Dividends | NASDAQ:LENZ | Benzinga

July 12, 2026 | benzinga.com

LENZ Therapeutics (LENZ) Stock Fair Value Moves Lower As Analysts Reset Growth Assumptions

July 11, 2026 | finance.yahoo.com

Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)

July 10, 2026 | theglobeandmail.com

LENZ Therapeutics Launches Telehealth Access for VIZZ Alongside National TV Campaign

July 6, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGFY, CRDL, LENZ, and AARD Company Descriptions

Aardvark Therapeutics NASDAQ:AARD

$6.54 +0.13 (+2.03%)

Closing price 04:00 PM Eastern

Extended Trading

$6.52 -0.01 (-0.23%)

As of 07:34 PM Eastern

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Agrify NASDAQ:AGFY

$22.22 +1.63 (+7.93%)

As of 08/13/2026

Agrify Corporation offers hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. It offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. The company also provides associated services comprising consulting, engineering, and construction. In addition, the company offers hydrocarbon, alcohol, solventless, post-processing, and lab equipment, as well as provides indoor farming solutions. In addition, it offers equipment and services in a contract and purchase order. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Troy, Michigan.

Cardiol Therapeutics NASDAQ:CRDL

$1.80 +0.09 (+5.26%)

Closing price 04:00 PM Eastern

Extended Trading

$1.77 -0.03 (-1.44%)

As of 07:34 PM Eastern

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

LENZ Therapeutics NASDAQ:LENZ

$4.73 +0.13 (+2.83%)

Closing price 04:00 PM Eastern

Extended Trading

$4.84 +0.11 (+2.22%)

As of 07:57 PM Eastern

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AGFY, CRDL, LENZ, and AARD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AGFY, CRDL, LENZ, and AARD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AGFY, CRDL, LENZ, and AARD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGFY, CRDL, LENZ, and AARD Company Descriptions

Aardvark Therapeutics NASDAQ:AARD

Agrify NASDAQ:AGFY

Cardiol Therapeutics NASDAQ:CRDL

LENZ Therapeutics NASDAQ:LENZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AGFY, CRDL, LENZ, and AARD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AGFY, CRDL, LENZ, and AARD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AGFY, CRDL, LENZ, and AARD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AGFY, CRDL, LENZ, and AARD Company Descriptions

Aardvark Therapeutics NASDAQ:AARD

Agrify NASDAQ:AGFY

Cardiol Therapeutics NASDAQ:CRDL

LENZ Therapeutics NASDAQ:LENZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools